In a recent long-term follow-up of 18 patients with CYP24A1 and SLC34A1 mutations, impaired kidney function at a mean age of 23.8 years was found in 77%, including two adults with end-stage renal disease. The gene discussed is SLC34A1; the disease is stage 5 chronic kidney disease.